Publications by authors named "Jack Moye"

Claim this Profile
B
Building a growing genomic repository for maternal and fetal health through the PING Consortium.
Clara M Abdelmalek, Shriya Singh, Blain Fasil, Allison R Horvath, Sarah B Mulkey, Jack Moye

Pediatr Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zika in Infants and Pregnancy (ZIP) study: results from a prospective international cohort study of prenatal Zika virus infection and adverse fetal and infant outcomes.
Jill Farnell Lebov, Martha Nason, Kristen B Stolka, Ricardo Ximenes, Marisa M Mussi-Pinhata, Jack Moye

BMC Pregnancy Childbirth· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolating the effects of HIV infection and HIV exposure on epigenetic profiles in infants using historical data from the Mothers and Infants Cohort Study.
Jasmine Douglas, Ziyi Wang, Francesca Zumpano, Jaya M Satagopan, Jack Moye

EBioMedicine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results.
Helena Rabie, Dwight E Yin, Shawn Ward, Yasha Rani, Lauren Ziemba, Jack Moye

Pediatr Infect Dis J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07-523LS in Newborn Infants Exposed to HIV-1.
Coleen K Cunningham, Elizabeth J McFarland, Petronella Muresan, Edmund V Capparelli, Charlotte Perlowski, Jack Moye

J Pediatric Infect Dis Soc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children.
Matthew S Kelly, Coleen K Cunningham, Elizabeth J McFarland, Mark J Giganti, Jane C Lindsey, Jack Moye

Open Forum Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study.
Adrie Bekker, Edmund V Capparelli, Mark Mirochnick, Diana F Clarke, Mark F Cotton, Jack Moye

J Antimicrob Chemother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building a growing genomic data repository for maternal and fetal health through the PING Consortium.
Clara M Abdelmalek, Shriya Singh, Blain Fasil, Allison R Horvath, Sarah B Mulkey, Jack Moye

medRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age.
Adrie Bekker, Jincheng Yang, Jiajia Wang, Mark F Cotton, Mae Cababasay, Jack Moye

Pediatr Infect Dis J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal growth assessed via ultrasound in relation to maternal HIV infection status and antiretroviral regimens.
Paige L Williams, Brad Karalius, Kunjal Patel, Ann Aschengrau, Nahida Chakhtoura, Jack Moye

AIDS· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014.
Supattra Rungmaitree, Linda Aurpibul, Brookie M Best, Xiang Li, Meredith G Warshaw, Jack Moye

J Pediatric Infect Dis Soc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.
Kristina M Brooks, Jennifer J Kiser, Lauren Ziemba, Shawn Ward, Yasha Rani, Jack Moye

Lancet HIV· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adolescent and young adult research across the HIV prevention and care continua: an international programme analysis and targeted review.
Samantha Calabrese, Matt Perkins, Sonia Lee, Susannah Allison, Gina Brown, Jack Moye

J Int AIDS Soc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014.
Ann J Melvin, Ka Lai Yee, Kathryn P Gray, Mounika Yedla, Hong Wan, Jack Moye

J Acquir Immune Defic Syndr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children.
Coleen K Cunningham, Ruth A Karron, Petronella Muresan, Matthew S Kelly, Elizabeth J McFarland, Jack Moye

J Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure.
Agathe Béranger, Adrie Bekker, Belén P Solans, Mark F Cotton, Mark Mirochnick, Jack Moye

Clin Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.
Adrie Bekker, Edmund V Capparelli, Avy Violari, Mark F Cotton, Mae Cababasay, Jack Moye

Lancet HIV· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age.
Christine E MacBrayne, Richard M Rutstein, Andrew A Wiznia, Bobbie Graham, Carmelita G Alvero, Jack Moye

AIDS· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The National Children's Study Archive Model: A 3-Tier Framework for Dissemination of Data and Specimens for General Use and Secondary Analysis.
Peter K Gilbertson, Susan Forrester, Linda Andrews, Kathleen McCann, Lydia Rogers, Jack Moye

Front Public Health· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.
Paul Krogstad, Pearl Samson, Edward P Acosta, Jack Moye, Ellen Townley

J Pediatric Infect Dis Soc· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children.
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, Coleen K Cunningham, Charlotte Perlowski, Jack Moye

J Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children.
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, Coleen K Cunningham, Jennifer Libous, Jack Moye

J Infect Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.
Tammy Meyers, Pearl Samson, Edward P Acosta, Jack Moye, Ellen Townley

AIDS· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated.
Coleen K Cunningham, Ruth Karron, Petronella Muresan, Elizabeth J McFarland, Charlotte Perlowski, Jack Moye

Open Forum Infect Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital Cytomegalovirus and HIV Perinatal Transmission.
Kristina Adachi, Jiahong Xu, Bonnie Ank, D Heather Watts, Margaret Camarca, Jack Moye

Pediatr Infect Dis J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis